Trial NCT04906382

View at ClinicalTrials.gov 
Org. Study IDs: OSU-20173
Secondary IDs: NCI-2021-01367

Last trial update was posted on 2022-09-21

MeSH Interventions

Albumin-Bound Paclitaxel Carboplatin Paclitaxel Tislelizumab

MeSH Conditions

Adenocarcinoma, Clear Cell Carcinosarcoma Colorectal Neoplasms, Hereditary Nonpolyposis Endometrial Neoplasms Mixed Tumor, Mullerian Recurrence

Other Conditions

Lynch Syndrome Metastatic Endometrial Cancer Mismatch Repair Deficiency Recurrent Endometrial Cancer Recurrent Endometrial Carcinoma Recurrent Endometrial Clear Cell Adenocarcinoma Recurrent Uterine Corpus Carcinosarcoma

Stopping Reasons

Sponsor reorganization

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID